Ivoximab 20 mg/kg, ivgtt, Q4W + Temozolomide

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Ivoximab 20 mg/kg, ivgtt, Q4W + Temozolomide
Treatment and conditionWhere it standsTrials
Ivoximab 20 mg/kg, ivgtt, Q4W + Temozolomide for gliomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1